Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) EBIT Margin (2020 - 2025)

Rapid Micro Biosystems' EBIT Margin history spans 6 years, with the latest figure at 108.23% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 1624.0% to 108.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 141.1%, a 3686.0% increase, with the full-year FY2025 number at 141.1%, up 3686.0% from a year prior.
  • EBIT Margin hit 108.23% in Q4 2025 for Rapid Micro Biosystems, up from 145.09% in the prior quarter.
  • Over the last five years, EBIT Margin for RPID hit a ceiling of 108.23% in Q4 2025 and a floor of 394.6% in Q4 2022.
  • Historically, EBIT Margin has averaged 232.4% across 5 years, with a median of 198.08% in 2024.
  • Biggest five-year swings in EBIT Margin: plummeted -18742bps in 2022 and later skyrocketed 20227bps in 2023.
  • Tracing RPID's EBIT Margin over 5 years: stood at 279.49% in 2021, then crashed by -41bps to 394.6% in 2022, then soared by 51bps to 192.33% in 2023, then soared by 35bps to 124.47% in 2024, then increased by 13bps to 108.23% in 2025.
  • Business Quant data shows EBIT Margin for RPID at 108.23% in Q4 2025, 145.09% in Q3 2025, and 167.28% in Q2 2025.